Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

16.02 +0.17 (+1.07%)
Streaming Delayed Price Updated: 10:38 AM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Fulgent (FLGT) Q1 2026 Earnings Transcript ↗
Fulgent (FLGT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Earnings
Fulgent Genetics (NASDAQ:FLGT) Shares Dip Premarket After Q1 Earnings Miss Despite Revenue Beat ↗
Via Chartmill
Topics Earnings
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are moving on Friday? ↗
Via Chartmill
Fulgent Genetics (NASDAQ:FLGT) Shares Plunge on Weak 2026 Outlook After Mixed Q4 ↗
Via Chartmill
News headline image
Fulgent Genetics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Fulgent Genetics Earnings Preview ↗
Via Benzinga
Gapping stocks in Friday's session ↗
Via Chartmill
News headline image
Fulgent Genetics (FLGT) Earnings Transcript ↗
Fulgent Genetics (FLGT) Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Fulgent Genetics (FLGT) Earnings Call Transcript ↗
Fulgent Genetics (FLGT) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
FULGENT GENETICS INC (NASDAQ:FLGT) Beats Q3 2025 Earnings Estimates and Raises Guidance ↗
Fulgent Genetics Q3 2025 earnings beat expectations with a surprise profit, causing a 4% pre-market stock surge. The company also raised its full-year guidance. 
Via Chartmill
Topics Earnings
News headline image
A Peek at Fulgent Genetics's Future Earnings ↗
 
Via Benzinga
News headline image
Uncovering Potential: Fulgent Genetics's Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2025 ↗
 
Via Benzinga
News headline image
Fulgent Genetics: A Risky Bet or a Hidden Gem? ↗
Fulgent Genetics has seen its fortunes shift since the pandemic. Is it a solid investment or a risky bet? Join us as we break down its performance and management decisions. 
Via The Motley Fool
News headline image
Earnings Preview: Fulgent Genetics ↗
 
Via Benzinga
News headline image
Why Is Fulgent Genetics Stock Moving Higher Today? ↗
Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.< 
Via Benzinga
News headline image
Fulgent (FLGT) Q2 Revenue Jumps 16% ↗
Via The Motley Fool
News headline image
Why Fulgent Genetics Stock Was Crushing It on Friday ↗
The next-generation diagnostics specialist had a beat-and-raise second quarter. 
Via The Motley Fool
News headline image
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 1, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 2, 2025 ↗
 
Via Benzinga
News headline image
Fulgent Genetics Revenue Tops Estimates ↗
Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss. 
Via The Motley Fool
News headline image
Earnings Scheduled For February 28, 2025 ↗
 
Via Benzinga
News headline image
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024 ↗
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
The 3 Best Digital Health Stocks for Personalized Medicine ↗
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. 
Via InvestorPlace
News headline image
Earnings Scheduled For November 3, 2023 ↗
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.